Please click HERE to complete the study specific prescreening questionnaire.

This study investigates how an investigational medication works to improve small intestinal damage and reduce symptoms in people with celiac disease who are trying to maintain a gluten-free diet. Celiac disease is a condition where consuming gluten leads to damage in the small intestine. Participants in the study will be compared to those receiving a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.

Participants in the study will undergo certain procedures, including ingesting gluten-free and simulated inadvertent gluten exposure products. They will also have two upper gastrointestinal endoscopies with duodenal biopsies to assess the condition of their small intestine.

• Who can participate: Adults with a medically diagnosed history of celiac disease and ongoing intestinal damage may participate. Participants must have experienced gluten-related symptoms recently and be willing to undergo specific study procedures.
• Study details: Participants will consume gluten-free and simulated gluten exposure products as part of the study.